These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 29883532)

  • 21. Cystatin C-Guided Vancomycin Dosing in Critically Ill Patients: A Quality Improvement Project.
    Frazee E; Rule AD; Lieske JC; Kashani KB; Barreto JN; Virk A; Kuper PJ; Dierkhising RA; Leung N
    Am J Kidney Dis; 2017 May; 69(5):658-666. PubMed ID: 28131530
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diagnostic and prognostic value of serum cystatin C in critically ill children with acute kidney injury.
    Volpon LC; Sugo EK; Carlotti AP
    Pediatr Crit Care Med; 2015 Jun; 16(5):e125-31. PubMed ID: 25838149
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biomarkers in acute kidney injury (AKI).
    Teo SH; Endre ZH
    Best Pract Res Clin Anaesthesiol; 2017 Sep; 31(3):331-344. PubMed ID: 29248140
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Kinetic Glomerular Filtration Rate Estimation Compared With Other Formulas for Evaluating Acute Kidney Injury Stage Early After Kidney Donation.
    Hekmat R; Eshraghi H; Esmailpour M; Hassankhani GG
    Exp Clin Transplant; 2017 Feb; 15(Suppl 1):104-109. PubMed ID: 28260446
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The urine biomarker panel [IGFBP7]x[TIMP-2] (NephroCheck® parameter) does not correlate with IGFBP7 and TIMP-2 gene expression in urinary sediment.
    Knafl D; Müller M; Pajenda S; Genc Z; Hecking M; Wagner L
    PLoS One; 2017; 12(11):e0188316. PubMed ID: 29145491
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum creatinine and cystatin C provide conflicting evidence of acute kidney injury following acute ingestion of potassium permanganate and oxalic acid.
    Wijerathna TM; Gawarammana IB; Dissanayaka DM; Palanagasinghe C; Shihana F; Dassanayaka G; Shahmy S; Endre ZH; Mohamed F; Buckley NA
    Clin Toxicol (Phila); 2017 Nov; 55(9):970-976. PubMed ID: 28535124
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cystatin C: A Promising Marker of Renal Function in Patients with Systemic Lupus Erythematosus?
    Peixoto L; Aguiar P; de Bragança R; Martins JR; Acabado AJ; Ducla-Sores JL
    Acta Med Port; 2015; 28(3):333-41. PubMed ID: 26421786
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Estimation of Glomerular Filtration Rate Based on the Serum Cystatin C and Creatinine Values.
    Serezlija E; Serdarevic N; Begic L
    Clin Lab; 2017 Jul; 63(7):1099-1106. PubMed ID: 28792695
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cystatin C as an endogenous marker of glomerular filtration rate in renal transplant patients.
    Pöge U; Stoschus B; Stoffel-Wagner B; Gerhardt T; Klehr HU; Sauerbruch T; Woitas RP
    Kidney Blood Press Res; 2003; 26(1):55-60. PubMed ID: 12697978
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical Relevance of Differences in Glomerular Filtration Rate Estimations in Frail Older People by Creatinine- vs. Cystatin C-Based Formulae.
    Jacobs A; Benraad C; Wetzels J; Rikkert MO; Kramers C
    Drugs Aging; 2017 Jun; 34(6):445-452. PubMed ID: 28405944
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cisplatin nephrotoxicity is not detected by urinary cell-cycle arrest biomarkers in lung cancer patients.
    Toprak Z; Cebeci E; Helvaci SA; Toprak ID; Kutlu Y; Sakin A; Tukek T
    Int Urol Nephrol; 2017 Jun; 49(6):1041-1047. PubMed ID: 28255639
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Urine biomarkers give early prediction of acute kidney injury and outcome after out-of-hospital cardiac arrest.
    Beitland S; Waldum-Grevbo BE; Nakstad ER; Berg JP; Trøseid AS; Brusletto BS; Brunborg C; Andersen GØ; Sunde K
    Crit Care; 2016 Oct; 20(1):314. PubMed ID: 27716377
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The discrepancy between serum creatinine and cystatin C can predict renal function after treatment for postrenal acute kidney injury: multicenter study and pooled data analysis.
    Matsuki M; Tanaka T; Maehana T; Kyoda Y; Ichihara K; Hashimoto K; Yanase M; Matsukawa M; Adachi H; Takahashi S; Masumori N
    Clin Exp Nephrol; 2017 Oct; 21(5):852-857. PubMed ID: 28258496
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cystatin C in acute kidney injury.
    Bagshaw SM; Bellomo R
    Curr Opin Crit Care; 2010 Dec; 16(6):533-9. PubMed ID: 20736828
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biomarkers of acute kidney injury: the pathway from discovery to clinical adoption.
    Kashani K; Cheungpasitporn W; Ronco C
    Clin Chem Lab Med; 2017 Jul; 55(8):1074-1089. PubMed ID: 28076311
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Changes in serum cystatin C, creatinine, and C-reactive protein after cardiopulmonary bypass in patients with normal preoperative kidney function.
    Svensson AS; Kvitting JP; Kovesdy CP; Cederholm I; Szabó Z
    Nephrology (Carlton); 2016 Jun; 21(6):519-25. PubMed ID: 26396066
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Plasma NGAL predicts early acute kidney injury no earlier than s-creatinine or cystatin C in severely burned patients.
    Rakkolainen I; Vuola J
    Burns; 2016 Mar; 42(2):322-8. PubMed ID: 26724852
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Urinary [TIMP-2]·[IGFBP7] - Novel Biomarkers to Predict Acute Kidney Injury.
    Kimmel M; Shi J; Wasser C; Biegger D; Alscher MD; Schanz MB
    Am J Nephrol; 2016; 43(5):375-82. PubMed ID: 27174659
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Value of Serum Cystatin C Measurement in the Diagnosis of Sepsis-Induced Kidney Injury and Prediction of Renal Function Recovery.
    Leem AY; Park MS; Park BH; Jung WJ; Chung KS; Kim SY; Kim EY; Jung JY; Kang YA; Kim YS; Kim SK; Chang J; Song JH
    Yonsei Med J; 2017 May; 58(3):604-612. PubMed ID: 28332367
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Assessment and prediction of acute kidney injury in patients with decompensated cirrhosis with serum cystatin C and urine N-acetyl-β-D-glucosaminidase.
    Kim TH; Lee HA; Seo YS; Lee YR; Yim SY; Lee YS; Suh SJ; Jung YK; Kim JH; An H; Yim HJ; Yeon JE; Byun KS; Um SH;
    J Gastroenterol Hepatol; 2019 Jan; 34(1):234-240. PubMed ID: 30062791
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.